The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Kopran Ltd

Kopran Ltd

BSE 524280 · NSE KOPRAN · ISIN INE082A01010 · Group T · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹191.70

-1.19%

BSE close, 28 August 2026

Market cap

₹925.64 cr

4.8 cr shares · Micro cap

Free float

₹514.39 cr

as published

P/E · P/B

27.5× · 2.23×

EPS ₹6.96 · BV ₹85.96

FY25-26 rev / PAT

305.65 / 30.40

₹ cr, as filed

Filings, window

15

3 selected · 20%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹107.00 52-WK HIGH ₹218.90 ₹191.70 76% of range
Against 52-week high-12.4%
Against 52-week low+79.2%
Day change-1.19%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹6.96
Price / earnings27.54×
Price / book2.23×
Book value — derived, price ÷ P/B₹85.96
Return on equity8.11%
Operating margin18.12%
Net margin10.71%

Consistency check

P/B ÷ P/E, which must equal ROE
8.10%
ROE as published
8.11%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 62.76 6.72 1.39 18.12% 10.71%
Mar-26 · Q 118.04 18.74 3.88 23.37% 15.88%
FY25-26 305.65 30.40 6.30 16.22% 9.95%

Quarter on quarter

Revenue, quarter on quarter
-46.8%
Net profit, quarter on quarter
-64.1%
Operating margin, quarter on quarter
-525 bps

Disclosure profile 15 filings in the window

0 median 17.0 p75 · 25 sector max 52 15 43th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Investor Presentation1
Results1
Selected sub-total3
Procedural
Clarification2
General2
Newspaper Publication2
SAST2
AGM / EGM1
Board Meeting1
ESOP Allotment1
Trading Window1
Procedural sub-total12
Total15

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group T, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

15 filings · 3 selected · busiest 2026-08-07

Filing rhythm · the twelve most recent

2026-08-072026-10-01

SelectedProcedural

Filings

15 in the window · 5 earlier on record

  1. 1 October 2026 ·

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sarvamangal Mercantile Company Ltd

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  2. 25 September 2026 ·

    Trading Window

    Closure of Trading Window

    Closure of trading window for Q2 Fy 2026-27 unaudited results

    Insider Trading / SAST / Closure of Trading Window View filing →

  3. 22 September 2026 ·

    General

    For Price Movement

    Price Movement

    Company Update / General View filing →

  4. 21 September 2026 ·

    Clarification

    Clarification sought from Kopran Ltd

    The Exchange has sought clarification from Kopran Ltd on September 21, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....

    Company Update / Clarification

  5. 16 September 2026 ·

    ESOP Allotment

    Allotment of ESOP / ESPS

    Allotment of ESOP Shares

    Company Update / Allotment of ESOP / ESPS View filing →

  6. 8 September 2026 ·

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for United Shippers Ltd

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  7. 1 September 2026 ·

    General

    Clarification For Inc rease In Scrip Volume

    Clarification for Inc rease in volume across exchanges

    Company Update / General View filing →

  8. 1 September 2026 ·

    Clarification

    Clarification sought from Kopran Ltd

    The Exchange has sought clarification from Kopran Ltd on September 01, 2026, with reference to Movement in Volume. The reply is awaited.

    Company Update / Clarification

  9. 18 August 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Proceedings of AGM, Voting results and Scrutinzer report

    AGM/EGM / AGM View filing →

  10. 10 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Result Q1 FY 2026-27

    Company Update / Newspaper Publication View filing →

  11. 7 August 2026 ·

    Investor Presentation

    Investor Presentation

    For Q1 FY 2026-27

    Company Update / Investor Presentation View filing →

  12. 7 August 2026 ·

    Results

    Result For Q1 FY 2026-27

    Unaudited Standalone and Consolidated Result for the quarter ended June 30, 2026

    Result / Financial Results View filing →

  13. 7 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Result Q1 FY 2026-27

    Unaudited Standalone and Consolidated Result for the Quarter Ended June 30, 2026

    Board Meeting / Outcome of Board Meeting View filing →

  14. 22 July 2026 ·

    Board Meeting

    Board Meeting Intimation for Intimation Of Board Meeting

    Kopran Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Results for the Q1 FY 2026-27

    Board Meeting / Board Meeting View filing →

  15. 20 July 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper Publication in FORM CAA3 as per NCLT direction

    Company Update / Newspaper Publication View filing →

RSS feed for Kopran Ltd · the 50 most recent filings